Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

323.94 -5.95 (-1.80%)
Streaming Delayed Price Updated: 12:15 PM EST, Dec 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
61 62 Next >
News headline image
Wall Street Stares At Weaker Open On Rate Anxiety, Hopes For Better Earnings: Analyst Pencils Key S&P 500 Support Level ↗
Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday. 
Via Benzinga
Topics Stocks
News headline image
Sector Superstars: 3 Stocks Generating the Most Buzz on Wall Street ↗
Discover the reasons behind three stocks attracting investor attention as they stand on the precipice of future growth. 
Via InvestorPlace
News headline image
Dow Jones Industrial Average Pushes Higher On Wednesday Despite Tepid Risk Appetite ↗
Via Talk Markets
Topics Stocks
News headline image
Market Whales and Their Recent Bets on AMGN Options ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Amgen? ↗
 
Via Benzinga
News headline image
Check Out What Whales Are Doing With AMGN ↗
 
Via Benzinga
News headline image
Amgen's Options: A Look at What the Big Money is Thinking ↗
 
Via Benzinga
News headline image
3 Tried and True Dividend Stocks to Buy for Your Portfolio ↗
These dividend stocks to buy represent time-tested companies with significant growth potential. Dive in now to strengthen your portfolio. 
Via InvestorPlace
News headline image
The Option Market Shows The Way Through This Low-Volume, Fed-Driven Melt-Up ↗
The S&P 500 ended today’s session a little more than 1% higher than where it started. At the same time, trading volume in equities has been very light. 
Via Talk Markets
Topics Stocks
News headline image
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday ↗
 
Via Benzinga
News headline image
Market Briefing For Monday, May 6, 2024 ↗
So prospects for a Fed rate-cut are enhanced by 'mediocre or bad' news on Jobs and Manufacturing fronts. Not a lot; but helps as at least it's not particularly more inflationary; and not a bad... 
Via Talk Markets
Topics Economy
News headline image
Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update ↗
As the demand for obesity drugs continues to surge, biopharma companies are eagerly seizing the opportunity to capitalize on the trend. 
Via Benzinga
News headline image
Dow Jones Industrial Average Gains 450 Points As Investors Up Rate Cut Bets After Softer NFP ↗
The Dow Jones Industrial Average gained nearly 1.2% on Friday after a broad miss from US Nonfarm Payrolls) and other key labor data revealed a steep weakening in the US domestic economy, sparking... 
Via Talk Markets
Topics Economy Stocks
News headline image
Why Amgen Stock Zoomed Nearly 12% Higher Today ↗
The company delivered solid quarterly results, but its discussion of an investigational drug is what really gave its shares a pop. 
Via The Motley Fool
News headline image
Stocks Rally As Jobs Report Rekindles Rate Cut Hopes, Apple Rockets, Bitcoin Soars Above $61,000: What's Driving Markets Friday? ↗
A weaker-than-expected jobs report sparked a widespread market rally in the last session of the week, as traders increased expectations on potential interest rate cuts later this year. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review ↗
The Nasdaq regained its 50-day line Friday. The other indexes hit resistance. 
Via Investor's Business Daily
Topics Economy
News headline image
Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value ↗
Amgen earnings beat estimates, and MariTide's promising Phase 2 results suggest significant differentiation from competitors. 
Via Benzinga
Topics Earnings
News headline image
Why Is WideOpenWest (WOW) Stock Up 30% Today? ↗
WideOpenWest stock is up on Friday after the technology company received a $4.80 per share in cash takeover offer for WOW shares. 
Via InvestorPlace
News headline image
Wage Growth Slows – Stock Market Celebrates, Five Real Reasons Apple Is Running Up ↗
To gain an edge, this is what you need to know today. 
Via Benzinga
News headline image
AMGN Stock Alert: Is Amgen the Next Hot Weight-Loss Drug Company? ↗
Amgen (AMGN) stock is soaring after the company's CEO said he was "very encouraged" by interim data for Amgen's new weight-loss drug. 
Via InvestorPlace
News headline image
Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Wall Street Looks To Feed Off Apple's Post-Earnings Power But Key Jobs Data May Upset The Cart: Analyst Says 'A Lot Of These Clouds Will Lift' If This Happens ↗
Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evident ahead of the all-important non-farm payrolls report. 
Via Benzinga
News headline image
Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Amgen Stock Adds Good Weight After CEO's Update On Experimental Drug Rivaling Ozempic, Nixing Oral Weight-Loss Candidate ↗
MariTide, formerly AMG 133, is an injectable form of drug targeting two gut hormones — gastric inhibitory polypeptide receptor, or GIP, and glucagon-like peptide 1, or GLP-1. 
Via Benzinga
News headline image
Apple, Coinbase, Block, Amgen, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗
Thursday saw major U.S. indices closing on a positive note, with the Dow Jones Industrial Average climbing 0.85% to reach 38,225.66 
Via Benzinga
Topics Stocks
News headline image
AMGN Stock Earnings: Amgen Beats EPS, Beats Revenue for Q1 2024 ↗
AMGN stock results show that Amgen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment ↗
Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company said EPS decreased by 1% due to higher operating and interest expenses... 
Via Benzinga
News headline image
Amgen Beats First-Quarter Expectations, But Shares Slide As Investors Watch Obesity Space ↗
The company confirmed it's still running a midstage study of its obesity drug, MariTide. 
Via Investor's Business Daily
News headline image
Wall Street Inches Up After Powell's Inflation Remarks; Chipmakers Rebound; Gold, Crude Falter: What's Driving Markets Thursday? ↗
U.S. stock markets surged during Thursday’s midday trading session in New York, with major averages all showing gains. 
Via Benzinga
Topics Economy
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.